VIDEO: Faricimab shows good visual stability, extended treatment intervals at 1 year

WAILEA, Hawaii — In this Healio Video Perspective from Retina 2024, Ferhina S. Ali, MD, MPH, presents real-world data from the FARETINA-AMD study investigating faricimab for the treatment of neovascular age-related macular degeneration.
“What we saw with our patients that were getting faricimab over our study period, which was soon after drug approval, is that most of these patients were not treatment naïve and that they had been on treatment prior. Most of them had been on treatment with aflibercept and they were switched to faricimab treatment,” she said. “We saw

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart